Home Newsfeeds Tesla Places 4nm Chip Orders With TSMC

General

Tesla Places 4nm Chip Orders With TSMC

-DigiTimes

byBill Haddad

December 21, 2022

1 minute read

-DigiTimes

Bausch Health to Appeal XIFAXAN Patent Decision to U.S. Court of Appeals for the Federal Circuit, Says Expects Decision To Issue Within 12-18 Months

By Michael Horton

August 10, 6:01 PM

Bausch Health Companies Inc. (TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company's July 28, 2022, press release, the U.S. District Court

BHC

Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned

By Vandana Singh

December 27, 1:42 PM

With recent merger and acquisition deals in the targeted radiopharmaceutical therapy (TRT) space, on Tuesday, Oppenheimer noted that Fusion Pharmaceuticals Inc (NASDAQ: FUSN) is potentially the sole remaining clinical-stage player with a robust supply chain.

AZN

EXCLUSIVE: Issuance Of New Reimbursement-Related Codes Validates Commercial Opportunity For HeartSciences’ Flagship Product

By Vandana Singh

October 19, 8:45 AM

The American Medical Association has issued new industry-first Category III Current Procedural Terminology (CPT) codes for AI assistive algorithmic ECG risk assessment for cardiac dysfunction.

HSCS

Architectural Services Company Apogee Boosts Shares Buyback Program By 2M Shares, Declares Dividend

By Shivani Kumaresan

October 6, 8:46 AM

Apogee Enterprises Inc (NASDAQ: APOG) said its Board of Directors has increased the company's existing share

APOG

Tesla Places 4nm Chip Orders With TSMC

Related Posts

Bausch Health to Appeal XIFAXAN Patent Decision to U.S. Court of Appeals for the Federal Circuit, Says Expects Decision To Issue Within 12-18 Months

Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned

EXCLUSIVE: Issuance Of New Reimbursement-Related Codes Validates Commercial Opportunity For HeartSciences’ Flagship Product

Architectural Services Company Apogee Boosts Shares Buyback Program By 2M Shares, Declares Dividend